Intellia stock price.

Intellia Therapeutics, Inc. Common Stock (NTLA) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide...2 days ago · On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ:NTLA) and slightly increased the price target to $73 from $72. The adjustment …Stock analysis for Intellia Therapeutics Inc (NTLA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Intellia Therapeutics Stock Earnings. The value each NTLA share was expected to gain vs. the value that each NTLA share actually gained. Intellia Therapeutics ( NTLA) reported Q3 2023 earnings per share (EPS) of -$1.38, beating estimates of -$1.50 by 7.99%. In the same quarter last year, Intellia Therapeutics 's earnings per share (EPS) was -$1.49.Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis. In depth view into NTLA (Intellia Therapeutics) stock including the latest price, news, dividend history, earnings information and …

3 days ago · View Intellia Therapeutics, Inc NTLA investment & stock information. Get the latest Intellia Therapeutics, Inc NTLA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Intellia Therapeutics, Inc. NTLA is a clinical-stage genome ... Intellia’s stock has plunged 22.7% in the past year ... You'll now be able to see real-time price and activity for your symbols on ...04:03 PM ET 03/02/2023. The Food and Drug Administration cleared Intellia Therapeutics ( NTLA) to begin testing its CRISPR gene-editing technology in people on Thursday, leading NTLA stock to jump ...24 Nov 2023 ... Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing ...NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course ...

Intellia Therapeutics Inc Stock Price History. Intellia Therapeutics Inc’s price is currently up 7.53% so far this month. During the month of December, Intellia Therapeutics Inc’s stock price has reached a high of $33.60 and a low of $26.95. Over the last year, Intellia Therapeutics Inc has hit prices as high as $47.48 and as low as $22.67 ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Intellia Therapeutics Inc’s Stock Price as of Market Close. As of November 22, 2023, 4:00 PM, CST, Intellia Therapeutics Inc’s stock price was $30.26. Intellia Therapeutics Inc is up 6.32% from its previous closing price of $28.46. During the last market session, Intellia Therapeutics Inc’s stock traded between $28.43 and $29.84.Get the latest Intellia Therapeutics Inc. (NTLA) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. The latest closing stock price for Intellia Therapeutics as of January 05, 2024 is 28.63. The all-time high Intellia Therapeutics stock closing price was 176.78 on September 03, 2021. The Intellia Therapeutics 52-week high stock price is 47.48, which is 65.8% above the current share price. The Intellia Therapeutics 52-week low stock price is 22 ... Intellia Therapeutics, Inc. Common Stock (NTLA) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. CRISPR specialist Intellia Therapeutics on Thursday said it will lay off about 15% of its workforce as it pauses some early-stage research.. The cuts come a little over three months after Intellia, one of the first companies founded to turn the gene editing technology into medicines, received a green light from U.S. regulators to begin a late …Intellia Therapeutics, Inc. Common Stock (NTLA) Pre-Market Stock Quotes ... You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com.

Intellia Thera CS (NTLA) $27.15 0.59 (2.13%) 16:00 EST NTLA Stock Quote Delayed 30 Minutes.Intellia Therapeutics Inc stock price (NTLA) NASDAQ: NTLA. ... Intellia Therapeutics Inc stock performance at a glance. Check Intellia Therapeutics Inc’s past financial performance, like revenue or net income, plus the top …Intellia Therapeutics Inc has risen 7.93% over the past month, closing at $28.46 on November 21. During this period of time, the stock fell as low as $28.15 and as high as $33.60. NTLA has an average analyst recommendation of Strong Buy. The company has an average price target of $78.45. NTLA has an Overall Score of 59.Intellia Therapeutics Stock Earnings. The value each NTLA share was expected to gain vs. the value that each NTLA share actually gained. Intellia Therapeutics ( NTLA) reported Q3 2023 earnings per share (EPS) of -$1.38, beating estimates of -$1.50 by 7.99%. In the same quarter last year, Intellia Therapeutics 's earnings per share (EPS) was -$1.49.Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest...The above is based on 19 Wall Street analysts offering 12-month price targets for Intellia in the last 3 months. The average price target is $173.11 with a high forecast of $238.00 and a low ...Dec 3, 2021 · Intellia Therapeutics, Inc. Common Stock (NTLA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

NTLA - Intellia Therapeutics, Inc. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqGM)

On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA ) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.Yet despite these upgrades, the analysts cut their price target 8.0% to US$76.36, implicitly signalling that the ongoing losses are likely to weigh negatively on Intellia Therapeutics' valuation.Jan 5, 2024 · Intellia Therapeutics, Inc. Stock price Berne S.E. Equities 38I US45826J1051 ... About the Intellia Therapeutics, Inc. stock forecast. As of 2024 February 18, Sunday current price of NTLA stock is 27.720$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Intellia Therapeutics stock price has been showing a declining tendency so we believe that similar market …When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll wan...3 days ago · Intellia Therapeutics Inc. Watch NEW Set a price target alert Premarket Last Updated: Feb 21, 2024 6:22 a.m. EST Delayed quote $ 27.27 0.12 0.44% Before Hours Volume: 480 Advanced Charting... Intellia Therapeutics has an announcement scheduled for December 31, 2023 regarding their recent Phase 1/2 trial of NTLA-2002. As of now, the drug has a 62.5% ...Trefis Estimates Intellia Therapeutics Valuation At $26.00 Per Share · Valuation Derived From: [1] Price To Sales Ratio (P/S) Based Estimate · [1] Price To Sales ...NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. Visitors trend 2W 10W 9M. 27.15-0.59 (-2.13%) At close: 04:00PM EST. ... Intellia Therapeutics, Inc., a genome editing company ...

Intellia Therapeutics, Inc. Common Stock (NTLA) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.

Intellia Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time NTLA stock price.

NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Intellia Therapeutics, Inc. (NTLA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. Zacks.4 days ago · Intellia Therapeutics, Inc. (NTLA) Stock Price, Quote & News - Stock Analysis 29.61 +1.38 (4.89%) At close: Feb 12, 2024, 4:00 PM 29.80 +0.19 (0.64%) Pre-market: …With Intellia Therapeutics stock trading at $25.09 per share, the total value of Intellia Therapeutics stock (market capitalization) is $2.25B. Intellia Therapeutics stock was originally listed at a price of $22.10 in May 6, 2016. If you had invested in Intellia Therapeutics stock at $22.10, your return over the last 7 years would have been 13. ...6 days ago · 2. Intellia Therapeutics. Intellia currently makes up a little more than 3% of Wood's healthcare fund, as the 14 th largest position. The company doesn't yet have a …Intellia Therapeutics, Inc. Stock price Deutsche Boerse AG Equities 38I US45826J1051 Biotechnology & Medical Research Market Closed - Deutsche Boerse AG. Other stock markets. 10:30:11 2024-01-12 am EST 5-day change ...Intellia Therapeutics Inc Stock Price History. Intellia Therapeutics Inc’s price is currently down 0.36% so far this month. During the month of November, Intellia Therapeutics Inc’s stock price has reached a high of $29.75 and a low of $24.38. Over the last year, Intellia Therapeutics Inc has hit prices as high as $57.49 and as low as $22. ...Real time Intellia Therapeutics (NTLA) stock price quote, stock graph, news & analysis. Intellia Therapeutics (NTLA) Stock Key Data. Summary Additional Data Analysts Historical Quotes. ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months.View the latest Intellia Therapeutics Inc. (NTLA) stock price, news, historical charts, analyst ratings and financial information from WSJ.Intellia Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time NTLA stock price. Intellia Therapeutics stock price stood at $26.10. According to the latest long-term forecast, Intellia Therapeutics price will hit $30 by the end of 2024 and ...

Stock analysis for Intellia Therapeutics Inc (NTLA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Intellia Therapeutics, Inc. is an American clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. The company's in vivo programs use intravenously administered CRISPR as the therapy, in which the company's proprietary delivery technology enables highly precise ... The latest price target for . Intellia Therapeutics (NASDAQ: NTLA) was reported by Oppenheimer on November 13, 2023.The analyst firm set a price target for $70.00 expecting NTLA to rise to within ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the Intellia Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data Intellia Therapeutics's NTLA shares and potentially its market environment have been in bearish cycle last 12 months (if exists). Instagram:https://instagram. cheaper by the dozen 3 movienicaragua on world maplocal fm radio stations near meradio towers near me On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ:NTLA) and slightly increased the price target to $73 from $72. The adjustment follows Intellia's fourth ...In other words, there will be updates along the way and the share price will go up or down depending on the updates. In other words, one doesn't have to wait for a long time for price movement ... is jojo siwa really having a babyemeline rochefeuille Intellia Therapeutics (NTLA Quick Quote NTLA - Free Report) reported third-quarter 2023 loss of $1.38 per share, narrower than the Zacks Consensus Estimate of a loss of $1.52. In the year-ago ... rosabell laurenti sellers nudes 5 days ago · The Intellia Therapeutics Inc stock price fell by -0.99% on the last day (Wednesday, 21st Feb 2024) from $27.15 to $26.88. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 3.88% from a day low at $26.26 to a day high of $27.28. The price has been going up and down for this period, and there has been a 1.17% ... The stock price of Intellia Therapeutics, a biotechnology company developing treatments using a CRISPR gene-editing system, has seen a significant 31% fall in a month while it is down 34% over the ...